2007: Muscle Biology, Myositis and Myopathies
Search or Browse by Day

Muscle Biology, Myositis and Myopathies

Saturday, November 10, 2007
1654
Frequency of Metabolic Myopathies in the Biochemical Analysis of Muscle Disease
1655
Abnormal Glucose and Lipid Metabolism and Impaired Growth and Development are Frequent Endocrine Findings in Juvenile Myositis
1656
Changes in Fiber Type Characteristics in Patients with Polymyositis and Dermatomyositis; a Feature Occurring in the Chronic, Rather Than Early State of Disease
1657
Idiopathic Inflammatory Myopathies in a Large Population-based Sample: Incidence and Patient Characteristics
1658
Race is a Major Predictor of Death in Patient’s with Idiopathic Inflammatory Myopathies (IIM)
1659
Towards an Abbreviated Cutaneous Assessment Tool (CAT) in Juvenile Dermatomyositis
1660
Clinical Features of Hemophagocytic Syndrome in Patients with Dermatomyositis
1661
Pulmonary Involment in Inflamatory Myopathies
1662
Successful Treatment of Refractory Interstitial Pneumonia in Patients with Amyopathic Dermatomyositis by Combination Immunosuppressive Therapy
1663
Clinical Classification of Dermatomyositis Using Myositis-Specific Autoantibodeis and Newly Found Autoantibodies in Patients with Dermatomyositis
1664
Myositis-Specific Autoantibodies are Associated with Specific Histopathological Features on Muscle Biopsies
1665
Clinical Features of Japanese Patients with Anti-Asparaginyl tRNA Synthetase Autoantibodies: The Immunogenetic Backgrounds
1666
HLA-DPB1*0101 Discriminates Between Anti-Jo-1 and Anti-PM-Scl Antibody Positive UK Caucasians with Idiopathic Inflammatory Myopathy (IIM)
1667
Increased Serum BAFF Levels in Patients with Inflammatory Myopathies
1668
Identification of NADH-Tetrazolium Reductase (NADH-TR) as a Marker of Microvascular Regeneration in Dermatomyositis
1669
Comparison of Transgenic Mice as an Animal Model for Calcinosis in Juvenile Dermatomyositis (JDM)
1670
Amelioration of Experimental Arthritis by a Calpain-inhibitory Compound
1671
Human Cytomegalovirus- A Possible Activator of the Immune System in Polymyositis and Dermatomyositis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>